[1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110-21.10.1056/NEJMra110035922129255]Search in Google Scholar
[2. Zirkzee EJ, Steup-Beekman GM, van der Mast RC, Bollen EL, van der Wee NJ, Baptist E, et al. Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy. J Rheumatol. 2012;39(11):2118-26.10.3899/jrheum.12054522984275]Search in Google Scholar
[3. Cesar Magro-Checa, Elisabeth J. Zirkzee, Tom W. Huizinga, Gerda M, Steup-Beekman. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs 2016; 76:459-483 DOI 10.1007/s40265-015-0534-3.10.1007/s40265-015-0534-3479145226809245]Search in Google Scholar
[4. Tomic-Lucic A, Petrovic R, Radak-Perovic M, et al. Late-onset systemic lupus erythematosus: clinical features, course, and prognosis. Clin Rheumatol 2013; 32: 1053-58.10.1007/s10067-013-2238-y23515605]Search in Google Scholar
[5. Tomić Lučić A, Petrović R. Sistemski eritemski lupuskasni početak, tok i ishod. Acta Rheumatologica Belgradensia 2011; 41(Supp 1): 89.]Search in Google Scholar
[6. Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011;41(1):1-11.10.1016/j.semarthrit.2010.08.00120965549]Search in Google Scholar
[7. Kampylafka EI, Alexopoulos H, Kosmidis ML, Panagiotakos DB, Vlachoyiannopoulos PG, Dalakas MC, et al. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. Plos One. 2013;8(2):e55843.10.1371/journal.pone.0055843357056023424638]Search in Google Scholar
[8. Raquel Faria, Joao Goncalves and Rita Dias. Neuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients? Rambam Maimonides Med J. 2017; 8(1):e001 doi: 10.5041/RMMJ.10276.]Search in Google Scholar
[9. Zirkzee EJ, Huizinga TW, Bollen EL, van Buchem MA, Middelkoop HA, van der Wee NJ, et al. Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus. 2014;23(1):31-8.10.1177/096120331351254024243776]Search in Google Scholar
[10. Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, et al. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum. 2012;42(2):179-85.10.1016/j.semarthrit.2012.03.01122595642]Search in Google Scholar
[11. Govoni M, Bortoluzzi A, Padovan M, et al. The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun 2016;74: 41-7.10.1016/j.jaut.2016.06.01327427403]Search in Google Scholar
[12. Perricone C, Pendolino M, Olivieri M, Conti F, Valesini G, Alessandri C. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus. Isr Med Assoc J 2015;17:171-8.]Search in Google Scholar
[13. Gerosa M, Poletti B, Pregnolato F, et al. Antiglutamate receptor antibodies and cognitive impairment in primary antiphospholipid syndrome and systemic lupus erythematosus. Front Immunol 2016;7:5.10.3389/fimmu.2016.00005]Search in Google Scholar
[14. Noureldine MH, Harifi G, Berjawi A, et al. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? Lupus 2016;25: pii: 0961203316651747.10.26226/morressier.56e174d0d462b8028d88a396]Search in Google Scholar
[15. Anisur Rahman.Conventional tratments in systemic lupus erythematosus. In: Gordon C, Isenberg D Systemic Lupus Erythematosus.Oxford University press, Oxford; 2016: 79-88.10.1093/med/9780198739180.003.0006]Search in Google Scholar
[16. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45(5):419-23.10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X]Search in Google Scholar
[17. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007;56: 265-73.10.1002/art.22305]Search in Google Scholar
[18. Fanouriakis A, Pamfil C, Rednic S, Sidiropoulos P, Bertsias G, Boumpas DT. Is it primary neuropsychiatric systemic lupus erythematosus? Performance of existing attribution models using physician judgment as the gold standard. Clin Exp Rheumatol 2016;34: 910-1.]Search in Google Scholar
[19. Alessandra Bortoluzzi, Carlo Alberto Scire, Stefano Bombardieri, Luisa Caniatti, Fabrizio Conti, Salvatore De Vita6, Andrea Doria et al. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (Oxford) 2015;54:891-98 doi:10.1093/rheumatology/keu384.]Search in Google Scholar
[20. Hanley G, Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol 2014; 10:338-47.10.1038/nrrheum.2014.15]Search in Google Scholar
[21. Rhodes B and Gordon C. Clinical features of systemic lupus erythematosus. In: Gordon C, Isenberg D Systemic Lupus Erythematosus.Oxford University press, Oxford; 2016, 45-62.10.1093/med/9780198739180.003.0004]Search in Google Scholar
[22. Sarbu N, Alobeidi F, Toledano P, et al. Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev 2015;14:153-9.10.1016/j.autrev.2014.11.001]Search in Google Scholar
[23. Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010;69:2074-82.10.1136/ard.2010.130476]Search in Google Scholar
[24. Sarbu N, Bargallo N, Cervera R. Advanced and conventional magnetic resonance imaging in neuropsychiatric lupus. Version 2. F1000Res. 2015 Jun 23 [revised 2015 Jul 28];4:16.10.12688/f1000research.6522.2450578826236469]Search in Google Scholar
[25. Gal Y, Twig G, Mozes O, Greenberg G, Hoffmann C, Shoenfeld Y. Central nervous system involvement in systemic lupus erythematosus: an imaging challenge. Isr Med Assoc J 2013;15:382-6.]Search in Google Scholar
[26. C Muangchan, R Van Vollenhoven, S Bernatsky, D Smith, M Hudson, M Inanc et al. Treatment Algorithms in Systemic Lupus Erythematosus . Arthritis Care & Research 2015; 67( 9): 1237-1245.10.1002/acr.2258925777803]Search in Google Scholar
[27. Gonzalez LA, Pons-Estel GJ, Zhang J, et al. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort. Lupus 2009;18: 822-30.10.1177/0961203309104392375915019578107]Search in Google Scholar
[28. Cavaco S, Martins da Silva A, Santos E, et al. Hydroxychloroquine and cognition in systemic lupus erythematosus. Lupus 2014;23.10.1177/0961203314530488]Search in Google Scholar
[29. Magro-Checa C, Zirkzee EJ, Huizinga TW, SteupBeekman GM. Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives. Drugs 2016;76:459-83.10.1007/s40265-015-0534-3479145226809245]Search in Google Scholar
[30. Fanouriakis A, Pamfil C, Sidiropoulos P, et al. Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study. Lupus 2016;25:627-36.10.1177/096120331562282126692040]Search in Google Scholar
[31. Fernandes Moca Trevisani V, Castro AA, Ferreira Neves Neto J, Atallah AAN. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database Syst Rev 2013;(2):CD002265.10.1002/14651858.CD002265.pub3682322223450535]Search in Google Scholar
[32. Higashioka K, Yoshida K, Oryoji K, et al. Successful treatment of lupus cerebrovascular disease with mycophenolate mofetil. Intern Med 2015;54:2255-9.10.2169/internalmedicine.54.458226328657]Search in Google Scholar
[33. Farinha F, Abrol E, Isenberg DA. Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus. Lupus 2016;25:1278-9.10.1177/096120331663163626873650]Search in Google Scholar
[34. C Pamfil, A Fanouriakis, L Damian, M Rinzis, P Sidiropoulos, G Tsivgoulis et al. EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology (Oxford) 2015; 54 (7): 1270-1278.10.1093/rheumatology/keu48225638807]Search in Google Scholar